Nitric oxide
Side effects
Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | |
|---|---|---|---|---|
| 1 | 2 | |||
| Dizziness | postmarketing | x | x | |
| Dyspnoea | postmarketing | x | x | |
| Headache | postmarketing | x | x | |
| Dry throat | postmarketing | x | x | |
| Chest discomfort | postmarketing | x | ||
| Atelectasis | x | |||
| Cerebral infarction | x | x | ||
| Gastrointestinal haemorrhage | x | x | ||
| Cardiac disorder | x | |||
| Haemorrhage | x | x | ||
| Hypotension | x | x | ||
| Periventricular leukomalacia | x | x | ||
| Mediastinal disorder | x | |||
| Methaemoglobinaemia | x | |||
| Nervous system disorder | x | |||
| Convulsion | x | x | ||
| Shock | x | |||
| Thrombocytopenia | x | |||
| Angiopathy | x | |||
| Haemorrhage intracranial | x | x | ||
| Pulmonary haemorrhage | x | x | ||
| Bradycardia | x | |||
| Blood and lymphatic system disorders | x | |||
Indications
Information about indications was extracted from the indications and usage sections of the labels.
Color scheme:
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |
